MERRILL HART: Open Payments
NPI 1225493984 · LAKE WALES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 39 payments from 8 companies in 2025. Trend: 2023 $603 · 2024 $1,198 · 2025 $991
Food & beverage: $892Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $390 |
| PFIZER INC. | 13 | $166 |
| Janssen Biotech, Inc. | 5 | $138 |
| ABBVIE INC. | 6 | $114 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| Lilly USA, LLC | 1 | $46 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Organon LLC | 1 | $15 |
Products named: DUPIXENT, TREMFYA, CIBINQO, SKYRIZI, EUCRISA, EBGLYSS, NEMLUVIO, Rhapsido.
Industry payments across FL — which companies pay providers there.
